Jürg Zimmermann

Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection.

Peter Meier, Pierre Acklin, Kamal Azzaoui, 2005, Current topics in medicinal chemistry.

Potent and Selective Inhibitors of the AbL-Kinase: Phenylaminopyrimidine (PAP) Derivatives.

Jürg Zimmermann, N. Lydon, H. Mett, 1997 .

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Jürg Zimmermann, Brian J. Druker, B. Druker, 1996, Nature Medicine.

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.

Bhabatosh Chaudhuri, Doriano Fabbro, Pascal Furet, 2002, Pharmacology & therapeutics.

Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives

Jürg Zimmermann, N. Lydon, H. Mett, 1997 .